Ignite Creation Date:
2025-12-24 @ 6:46 PM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT03151057
Status:
TERMINATED
Last Update Posted:
2024-03-12
First Post:
2017-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
Sponsor:
Organization: